A Phase 1/2, First-in-human, Open-label Study of Single-agent AWT020 in Patients with Progressive Locally Advanced or Metastatic Cancer

  • Voskoboynik, Mark (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date11/11/2311/11/25

Keywords

  • clinical trial
  • Metastatic Cancer
  • immunotherapy
  • PD-1